drugset / Trial / NCT00140972

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

NCT00140972

Phase 4 Completed 160 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip

Timeline

Start
2004-12-03
Primary completion
2005-06-27
Completion
2005-06-27

Publications

  • Results Zhang F, Li Z, Yang N, Wu D, Sun L, Wu H. The clinical study of etoricoxib in the treatment of Chinese patients with osteoarthritis: a randomized double-blind trial. Chinese J of Rheum. 2013;17(5):307-312.

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 75 mg
Subject Etoricoxib Small molecule 60 mg

Indications